Boltz Commits to Open Models as Pfizer, GSK, Takeda and BMS Sign On

Boltz says its tools are already used daily by scientists at Pfizer, GSK, Takeda and BMS, and argues such powerful models should remain open to all scientists rather than locked into a single pharma pipeline or exclusive partnership.

2026-11-18 ~ 2026-11-18 · 2 related posts